HIV-1 reactivation in HIV-latently infected dendritic cells by oral microorganisms and LPS

Cellular Immunology

Volumn 268, Issue 2, 2011, Pages 105-111

  Huang, C B ^a   Alimova, Y V ^a   Ebersole, J L ^a  

^a UNIVERSITY OF KENTUCKY COLLEGE OF DENTISTRY   (United States)

Author keywords

Dendritic cells; HIV latency; HIV viral replication; HIV 1 promoter; Lipopolysaccharide; Oral pathogens

Indexed keywords

ANTIRETROVIRUS AGENT; LIPOPOLYSACCHARIDE; PATTERN RECOGNITION RECEPTOR;

ADAPTIVE IMMUNITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INNATE IMMUNITY; MOUSE; MOUTH FLORA; MOUTH INFECTION; NONHUMAN; PORPHYROMONAS GINGIVALIS; PRIORITY JOURNAL; PROMOTER REGION; RETROVIRUS INFECTION; VIRUS LATENCY; VIRUS REACTIVATION;

CELL LINE; DENDRITIC CELLS; HIV INFECTIONS; HIV-1; HUMANS; LIPOPOLYSACCHARIDES; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; PROMOTER REGIONS, GENETIC; VIRUS ACTIVATION; VIRUS LATENCY; VIRUS REPLICATION;

BACTERIA (MICROORGANISMS); HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 79954419411     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2011.02.003     Document Type: Article

References (50)

1. T.R. Sterling, J.G. Bartlett, R.D. Moore, CD4+ lymphocyte level is better than HIV-1 plasma vial load in determining when to initiate HAART, in: Eighth Conference on Retroviruses and Opportunistic Infections, Chicago, IL, 2001 (abstract 519).
2. Jordan A., Bisgrove D., Verdin E. HIV reproducibly establishes a latent infection after acute infection of T cells in vitro. EMBO J. 2003, 22:1868-1877.
3. Siliciano J.D., Siliciano R.F. A long-term latent reservoir for HIV-1: discovery and clinical implications. J. Antimicrobial. Chemo. 2004, 54:6-9.
4. Nowak P., Barqasho B., Treutiger C.J., Harris H.E., Tracey K.J., Andersson J., Sonnerborg A. HMGB1 activates replication of latent HIV-1 in a monocytic cell-line, but inhibits HIV-1 replication in primary macrophages. Cytokine 2006, 34:17-23.
5. Smith B.A., Gartner S., Liu Y., Perelson A.S., Stilianakis N.I., Keele B.F., Kerkering T.M., Ferreira-Gonzalez A., Szakal A.K., Tew J.G., Burton G.F. Persistence of infectious HIV on follicular dendritic cells. J. Immunol. 2001, 166:690-696.
6. Moriuchi H., Moriuchi M., Mizell S.B., Ehler L.A., Fauci A.S. In vitro reactivation of human immunodeficiency virus from latently infected, resting CD4+ cells after bacterial stimulation. J. Infect. Dis. 2000, 181:2041-2044.
7. Gollapudi S., Gupta S., Thadepalli H. Salmonella typhimurium-induced reactivation of latent HIV-1 in promonocytic U1 cells is inhibited by trovafloxacin. Int. J. Mol. Med. 2000, 5:615-618.
8. Blanchard A., Montagnier L., Geougeon M.L. Influence of microbial infections on the progression of HIV disease. Trends Microbiol. 1997, 5:326-332.
9. Sato A., Iwasaki A. Induction of antiviral immunity requires Toll-like receptor signaling in both stromal and dendritic cell compartments. PNAS 2004, 101:16274-16279.
10. Wu L., KewalRamani N.V. Dendritic-cell interactions with HIV: infection and viral dissemination. Nat. Rev. Immunol. 2006, 6(11):859-868.
11. Turville S., Wilkinson J., Cameron P., Dable J., Cunningham A.L. The role of dendritic cell C-type lectin receptors in HIV pathogenesis. J. Leuk. Biol. 2003, 74:710-718.
12. Cohen N., Morisset J., Emilie D. Induction of tolerance by Porphyromonas gingivalis on APCS: a mechanism implicated in periodontal infection. J. Dent. Res. 2004, 83(5):429-433.
13. Jotwani R., Palucka A.K., Al-Quotub M., et al. Mature dendritic cells infiltrate the T cell-rich region of oral mucosa in chronic periodontitis: in situ, in vivo, and in vitro studies. J. Immunol. 2001, 167(8):4693-4700.
14. Cutler C.W., Jotwani R. Dendritic Cells at the Oral Mucosal Interface. JDR 2006, 85:678-689.
15. Newcomb G.M., Seymour G.J., Powell R.N. Association between plaque accumulation and Langerhans cell numbers in the oral epithelium of attached gingiva. J. Clin. Periodontol. 1982, 9:297-304.
16. Walsh L.J., Cleveland D.B., Cumming C.G. Quantitative evaluation of Langerhans cells in median rhomboid glossitis. J. Oral Pathol. Med. 1992, 21:28-32.
17. Moughal N.A., Adonogianaki E., Kinane D.F. Langerhans cell dynamics in human gingiva during experimentally induced inflammation. J. Biol. Buccale 1992, 20:163-167.
18. Qureshi M.N., Barr C.E., Seshamma T., Reidy J., Pomerantz R.J., Bagasra O. Infection of oral mucosal cells by human immunodeficiency virus type 1 in seropositive persons. J. Infect. Dis. 1995, 171(1):190-193.
19. Lü F.X., Jacobson R.S. Oral mucosal immunity and HIV/SIV infection. JDR 2007, 86(3):216-226.
20. Chou L.L., Epstein J., Cassol S.A., West D.M., He W., Firth J.D. Oral mucosal Langerhans' cells as target, effector and vector in HIV infection. J. Oral Pathol. Med. 2000, 29(8):394-402.
21. Cutler C.W., Jotwani R. Oral mucosal expression of HIV-1 receptors, co-receptors, and alpha-defensins: tableau of resistance or susceptibility to HIV infection?. Adv. Dent. Res. 2006, 19(1):49-51.
22. Brenchley J.M., Price D.A., Schacker T.W., Asher T.E., Silvestri G., Rao S., Kazzaz Z., Bornstein E., Lambotte O., Altmann D., Blazar B.R., Rodriguez B., Teixeira-Johnson L., Landay A., Martin J.N., Hecht F.M., Picker L.J., Lederman M.M., Deeks S.G., Douek D.C. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat. Med. 2006, 12:1365-1371.
23. Chen A.M., Khanna N., Stohlman S.A., Bergmann C.C. Virus-specific and bystander CD8 T cells recruited during virus-induced encephalomyelitis. J. Virol. 2005, 79:4700-4708.
24. O'Mahony L., O'Callaghan L., McCarthy J., Shilling D., Scully P., Sibartie S., Kavanagh E., Kirwan W.O., Redmond H.P., Collins J.K., Shanahan F. Differential cytokine response from dendritic cells to commensal and pathogenic bacteria in different lymphoid compartments in humans. Am. J. Physiol. Gastrointest. Liver Physiol. 2006, 290:839-845.
25. Tatakis D.N., Kumar P.S. Etiology and pathogenesis of periodontal diseases. Dent. Clin. North Am. 2005, 49:491-516.
26. Ebersole J.L., Cappelli D., Holt S.C. Periodontal diseases: to protect or not to protect is the question?. Acta Odontol. Scand. 2001, 59:161-1661.
27. González O.A., Ebersole J.L., Huang C.B. Oral infectious diseases: a potential risk factor for HIV virus recrudescence?. Oral Dis. 2009, 15(5):313-327.
28. Klebanoff S.J., Kazazi F., Van Voorhis W.C., Schlechte K.G. Activation of the human immunodeficiency virus long terminal repeat in THP-1 cells by a staphylococcal extracellular product. PNAS 1994, 91:10615-10619.
29. Kutsch Olaf, Levy David N., Kosloff Barry R., Shaw George M., Benveniste Etty N. CD154-CD40-induced reactivation of latent HIV-1 infection. Virology 2003, 314(1):261-270.
30. Ebner S., Ratzinger G., Krosbacher B., Schmuth M., Weiss A., Reider D., Kroczek R.A., Herold M., Heufler C., Fritsch P., Romani N. Production of IL-12 by human monocyte-derived dendritic cells is optimal when the stimulus is given at the onset of maturation, and is further enhanced by IL-4. J. Immunol. 2001, 166:633-641.
31. Kalinski P., Schuitemaker J.H., Hilkens C.M., Wierenga E.A., Kapsenberg M.L. Final maturation of dendritic cells is associated with impaired responsiveness to IFN-gamma and to bacterial IL-12 inducers: decreased ability of mature dendritic cells to produce IL-12 during the interaction with Th cells. J. Immunol. 1999, 162:3231-3236.
32. Lopatin D.E., Combs A., Sweier D.G., Fenno J.C., Dhamija S. Characterization of heat-inducible expression and cloning of HtpG (Hsp90 homologue) of Porphyromonas gingivalis. Infect. Immun. 2000, 68:1980-1987.
33. Chatfield C.H., Koo H., Quivey R.G. The putative autolysin regulator LytR in Streptococcus mutans plays a role in cell division and is growth-phase regulated. Microbiology 2005, 151:625-631.
34. Blankenship J.R., Heitman J. Calcineurin is required for Candida albicans to survive calcium stress in serum. Infect. Immun. 2005, 73(9):5767-5774.
35. Kesavalu L., Falk C.W., Davis K.J., Steffen M.J., Xu X., Holt S.C., Ebersole J.L. Biological characterization of lipopolysaccharide from Treponema pectinovorum. Infect. Immun. 2002, 70:211-217.
36. Walker S.G., Xu X., Altman E., Davis K.J., Ebersole J.L., Holt S.C. Isolation and chemical analysis of a lipopolysaccharide from the outer membrane of the oral anaerobic spirochete Treponema pectinovorum. Oral Microbiol. Immunol. 1999, 14(5):304-308.
37. Gehring A.J., Rojas R.E., Canaday D.H., Lakey D.L., Harding C.V., Boom W.H. The Mycobacterium tuberculosis 19-kilodalton lipoprotein inhibits gamma interferon-regulated HLA-DR and FcγR1 on human macrophages through toll-like receptor 2. Infect. Immun. 2003, 71:4487-4497.
38. Nat R., Radu E., Regalia T., Popescu L.M. Apoptosis in the immune system: 1. Fas-induced apoptosis in monocytes-derived human dendritic cells. J. Cell. Mol. Med. 2002, 6:223-234.
39. Lopez C.B., Yount J.S., Moran T.M. Toll-like receptor-independent triggering of dendritic cell maturation by viruses. J. Virol. 2006, 80:3128-3134.
40. Rossi M., Young J.W. Human dendritic cells: potent antigen-presenting cells at the crossroads of innate and adaptive immunity. J. Immunol. 2005, 175:1373-1381.
41. De Graaff P.M.A., de Jong E.C., van Capel T.M., van Dijk M.E.A., Roholl P.J.M., Boes J., Luytjes W., Kimpen J.L.L., van Bleek G.M. Respiratory syncytial virus infection of monocyte-derived dendritic cells decreases their capacity to activate CD4 T cells. J. Immunol. 2005, 175:5904-5911.
42. Means T.K., Hayashi F., Smith K.D., Aderem A., Luster A.D. The Toll-Like Receptor 5 Stimulus Bacterial Flagellin Induces Maturation and Chemokine Production in Human Dendritic Cells. J. Immunol. 2003, 170:5165-5175.
43. Bouchon A., Facchetti F., Weigand M.A., Colonna M. TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature 2001, 410(6832):1103-1107.
44. Ogata M., Nandate K., Kawasaki T., Kawasaki C., Ozaki M., Sigematsu A. A platelet activating factor receptor antagonist inhibits cytokine production in human whole blood by bacterial toxins and live bacteria. Anesth. Analg. 2004, 98:1767-1772.
45. Nadesalingam J., Dodds A.W., Reid K.B., Palaniyar N. Mannose-binding lectin recognizes peptidoglycan via the N-acetyl glucosamine moiety, and inhibits ligand-induced proinflammatory effect and promotes chemokine production by macrophages. J. Immunol. 2005, 175:1785-1794.
46. Shattock R.J., Haynes B.F., Pulendran B., Flores J., Esparza J. Improving defences at the portal of HIV entry: mucosal and innate immunity. A summary report from a Global HIV Vaccine Enterprise Working Group. PLoS Med. 2007, 4(12):e348. 10.1371/journal.pmed.004034.
47. Nakayama M., Underhill D.M., Petersen T.W., Li B., Kitamura T., Takai T., Aderem A. Paired Ig-like receptors bind to bacteria and shape TLR-mediated cytokine production. J. Immunol. 2007, 178:4250-4425.
48. Huang C.B., Emerson K.A., Gonzalez O.A., Ebersole J.L. Oral bacteria induce a differential activation of human immunodeficiency virus-1 promoter in T cells, macrophages and dendritic cells. Oral Microbiol. Immunol. 2009, 24(5):401-407.
49. González O.A., Ebersole J.L., Huang C.B. Supernatants from oral epithelial cells and gingival fibroblasts modulate human immunodeficiency virus type 1 promoter activation induced by periodontopathogens in monocytes/macrophages. Mol. Oral Microbiol. 2010, 25(2):136-149.
50. González O.A., Li M., Ebersole J.L., Huang C.B. HIV-1 reactivation induced by periodontal pathogens Fusobacterium nucleatum and Porphyromonas gingivalis involves TLR2 and TLR9 activation in monocytes/macrophages. Clin. Vaccine Immunol. 2010.